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13 ABSTRACT
14 The objective of the present study was to assess the effects on ovulation and reproductive 
15 performance of a single injection of either GnRH or hCG applied 9 days before the start of 
16 the seasonal breeding period in anovulatory anoestrus cows  compared with a 7-day 
17 progesterone-Ovsynch protocol. The study was conducted on four grass-based seasonal 
18 calving dairy herds in Ireland. The total number of cows in the herds was 2112, of which 488 
19 were diagnosed as anoestrus based on absence of behavioural oestrus during a 30 day period. 
20 Ovarian structures and the uterus were examined by transrectal ultrasound on all 488 
21 presumptive anestrus cows 9 days before mating start date (MSD). The number of corpora 
22 lutea (CL), number of large follicles (≥ 10 mm) and uterine reproductive tract score were 
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23 recorded. Only cows that had no CL, ultrasound reproductive tract score ≤ 2 and were ≥ 30 
24 days in milk (DIM) were enrolled in the study (n = 214). Cows were blocked by parity, DIM 
25 and body condition score and randomly assigned to one of four treatments: i.m. injection of 
26 gonadotropin releasing hormone analogue [GnRH; (n = 57)], i.m. injection of human 
27 chorionic gonadotropin [hCG; (n = 48)], 7-day Progesterone-Ovsynch protocol [P4OV; (n = 
28 60)] and Control (no hormonal intervention, n = 49).  A second ultrasound examination was 
29 performed 7 days after treatment to determine ovulatory response. There was a treatment 
30 effect on ovulation rate (P < 0.0001), whereby Control cows had a lesser ovulation rate 
31 compared with GnRH-, hCG- and P4OV-treated cows. Submission rate during the first 21 
32 days of the breeding period [SR21; (P = 0.74)], pregnant to first service [P/AI1; (P = 0.24)], 
33 pregnant within 42 days after the onset of breeding [P42; (P = 0.73)], and pregnant within 84 
34 days after the onset of breeding were not affected by treatment. A tendency was observed (P 
35 = 0.07) for greater likelihood of pregnancy within 21 days after the onset of breeding (P21) 
36 for P4OV and Control cows compared with GnRH- and hCG-treated cows. GnRH- and hCG-
37 treated cows tended (P = 0.10) to have greater P/AI1 when first service events occurred after 
38 day 21 of the breeding period compared with Control cows. P4OV cows had shorter MSD to 
39 first service interval (P = 0.0001) and shorter MSD to conception interval (P = 0.02) 
40 compared with Control, GnRH- and hCG-treated cows. In conclusion, treatment of anestrous 
41 cows with GnRH or hCG resulted in an increase in ovulation rate compared with untreated 
42 Control cows, but did not improve reproductive performance during the first 21 days of the 
43 breeding season. The best reproductive performance results were obtained with the P4OV 
44 treatment, but this treatment has the greatest cost, and has the greatest number of 
45 interventions.  The observation of good P/AI1 in hCG- and GnRH- treated cows when the 
46 first insemination occurred later than day 21 after MSD warrants further investigation, and 
47 suggests that these interventions should be applied earlier than 9 days before the farm MSD.
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49 releasing hormone
50 1. Introduction
51 The resumption of oestrous cycles before the breeding season is an important pre-
52 requisite to achieve high reproductive efficiency in seasonally calving herds [1]. Extended 
53 postpartum anovulation and anoestrous periods are common, with approximately 11 to 35% 
54 of dairy cows anoestrus at the start of the breeding period [2] or at 63 days after calving [3]. 
55 The date for the planned start of calving is set to maximize the use of pasture during lactation 
56 in seasonal calving pasture-based systems [4]. To achieve a concentrated calving pattern, 
57 high submission rates and pregnancy per AI (P/AI) are essential [5]. Delayed postpartum 
58 commencement of ovulatory oestrous cyclicity and poor expression of oestrus are associated 
59 with reduced conception rates and increased intervals from calving to conception [6].
60 Witlbank et al. [7] described three categories of anovulation: (1) Anovulation with 
61 follicle growth only to ‘emergence’ state of development (no ovarian follicles ≥ 8 mm in 
62 diameter) associated with a relative deficiency in FSH;  (2) anovulation with follicle growth 
63 to deviation but not ovulatory size, associated with low frequency pulses of LH and increased 
64 sensitivity to the negative feedback effects of estradiol on gonadotropin release, and (3) 
65 anovulation with follicular growth to larger than ovulatory follicle size (follicular cysts), 
66 often associated with an increased release of LH with an insensitivity to estradiol positive 
67 feedback. 
68 Human chorionic gonadotropin (hCG) and gonadotropin releasing hormone (GnRH) 
69 treatments have similar effects on the ovary [8], inducing ovulation [9] and the formation of 
70 accessory corpora lutea (CL) [10] with a significant increase in plasma progesterone 
71 concentrations achieved 7 days after treatment [11], [for review, see De Rensis et al.,2010 
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72 [12]]. Hence, these two hormones have been widely used in fixed time artificial insemination 
73 protocols in both dairy [13, 14]  and beef cattle [15] to cause ovulation or luteinisation of a 
74 dominant follicle and initiate a new follicular wave [16], and to increase endogenous 
75 progesterone (P4) production [17].
76 Exposure of anestrous cows to P4 may stimulate development and maturation of a 
77 dominant follicle by enhancing LH release, stimulating development of LH receptors in theca 
78 cells and secretion of estradiol by the follicle [2]. Treatment of anestrous cows with P4 
79 resulted in greater follicular fluid and circulating concentrations of oestradiol, increased 
80 pulsatile release of LH and increased numbers of receptors for LH in granulosa and theca 
81 cells in pre-ovulatory follicles [18, 19].
82 Therefore, the aim of the present pilot study was to assess the effects on ovulation and 
83 reproductive performance of a single injection of either GnRH or hCG applied 9 days before 
84 the start of the seasonal breeding period in anovulatory anoestrus cows to simplify herd 
85 management and to reduce costs compared with a 7-day progesterone-Ovsynch protocol. 
86 Specifically, we hypothesized that 1) treatment of non-cycling cows would result in a greater 
87 ovulation rate than no treatment; 2) treatment of non-cycling cows would shorten the interval 
88 from mating start date (MSD) to both insemination and conception. 
89 2. Material and methods 
90 2.1 Cattle, location and experimental design
91 All experimental procedures involving animals on this study were approved by the 
92 Teagasc Animals Ethics Committee. The study treatment and data collection schedule are 
93 illustrated in Figure 1. The study was conducted on 4 grass-based seasonal calving dairy 
94 herds located in the province of Munster, Ireland (n = 2112 Holstein-Friesian and Holstein-
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95 Friesian x Jersey cross cows in total), and all enrolled cows calved during the spring 
96 (February to April) of 2017.Within each herd, all cows (n = 2112) were marked with tail 
97 paint (Tell Tail markers GEA © Farm Technologies, Mt Maunganui, New Zealand) 39 days 
98 before MSD in order to capture data on estrous cyclicity. Any cows with intact tail paint at 
99 Day -9 relative to MSD (n = 488) were assumed to be anoestrus and were subjected to 
100 ultrasound scanning.
101
102 2.2 Ultrasound examination
103 Ovarian structures and ultrasound reproductive tract score (URTS) of the uterus were 
104 evaluated by transrectal ultrasound 9 days before the farm MSD (8.5 MHz transrectal 
105 transducer Ibex Pro, Ibex®, Colorado, USA). Information recorded included number of 
106 corpora lutea, number of large follicles (≥ 10 mm), number of small follicles (≥ 5 mm and < 
107 10 mm) and URTS, measured on a 4-point scale as previously described by Mee et al. (2009) 
108 [20]; G1: a typical spoke wheel-shaped lumen; G2: a spoke wheel-shaped lumen with an 
109 enlarged centre filled with a small volume (>2 mm, ≤5 mm) of fluid of mixed echogenicity; 
110 G3: a stellate-shaped lumen filled with a moderate volume (>5 mm, ≤10 mm) of fluid of 
111 mixed echogenicity; G4: a circular shaped lumen filled with a large volume (>10 mm) of 
112 fluid of mixed echogenicity. Only non-ovulatory cows with a UTRS ≤ 2 and ≥ 30 DIM were 
113 enrolled in the study. 
114 The percentage of cows not detected in estrus by tail paint was 23.1% (488/2112). 
115 The percentage of cows with intact tail paint that presented with a CL or were classified as 
116 having a URTS > 2 was 39.9% (195 out 488) and 16.1% (79 out 488), respectively. These 
117 cows were not enrolled, resulting in 214 cows being available for inclusion in the study.
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118 2.3 Treatment and AI
119 Anestrous cows were blocked by parity [primiparous (n = 32), second parity (n = 46), 
120 third parity or greater (n = 136)], DIM [early-calving  (≥ 70 DIM, n = 60), mid-calving (43 to 
121 69 DIM, n = 106), and late-calving (30 to 42 DIM, n = 48) at MSD] and body condition score 
122 [BCS, 1 to 5 scale  in 0.25 increments [21]] and randomly assigned to one of four treatments 
123 9 days before MSD. GnRH-treated cows (GnRH; n = 57) were administered an i.m injection 
124 of 2 mL of GnRH analogue containing 100 µg gonadorelin diacetate (Ovarelin ® 50 µg/mL, 
125 Ceva  Santé Animale, Libourne, France). Human chorionic gonadotropin-treated cows (n = 
126 48) were administered an i.m injection of 1500 IU hCG (Chorulon ®,  MSD Ireland Ltd., 
127 Dublin, Ireland). Progesterone-Ovsynch-treated cows (P4OV; n = 60) had a progesterone–
128 releasing intravaginal device (PRID E®; containing 1.55 g of progesterone; Ceva Santé 
129 Animale) inserted for 7 days with i.m. administration of prostaglandin F2α (Enzaprost®, 5 
130 mL equivalent to 25 mg dinoprost, Ceva Santé Animale) at device removal, and 
131 gonadotropin-releasing hormone containing  100 µg gonadorelin diacetate (Ovarelin ® 50 
132 µg/mL, Ceva  Santé Animale) was administrated at PRID insertion and 56 h after PRID 
133 removal. P4OV cows were inseminated 72 h after PRID removal (16 h after the second 
134 GnRH) coinciding with MSD (Day 0). Animals in the Control group (n = 49) did not receive 
135 any treatment.
136 A second ultrasound examination was performed 7 days after treatment (Day -2) on 
137 all cows to determine ovulatory response by visualizing the presence or absence of a CL on 
138 either ovary. Cows were deemed to have ovulated if a CL was observed, or deemed to have 
139 not had an ovulation if a CL was not observed on either ovary. 
140 All animals were served during the breeding season by AI after detection of estrus or 
141 tail paint removal, with the exception of the first service in the P4OV-treated cows, which 
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142 was fixed time AI on the first day of the breeding season (Day 0). Between 30 to 42 days 
143 after first service an ultrasound examination was conducted to determine pregnancy status 
144 and viability of the embryo. 
145 2.4 Reproductive parameters 
146 Reproductive records including MSD, service dates and pregnancy status at the end of 
147 the breeding season for each enrolled herd were obtained from the Irish Cattle Breeding 
148 Federation (ICBF) website. 
149 The 21-day submission rate (SR21) was constructed by coding cows with an 
150 insemination date within the first 21 days after MSD as 1, and cows without insemination 
151 date within the first 21 days after MSD were coded as 0.
152 Pregnant to first service (P/AI1) was coded as 1 if a cow was diagnosed pregnant by 
153 ultrasound on Day 38 ± 6 after the first service. Cows with more than one service, or where 
154 the cow was diagnosed as nonpregnant, were allocated a P/AI1 of zero. A similar description 
155 was used when the first service occurred during the first 21 days (P/AI1 ≤ 21) or later than 
156 the first 21 days (P/AI1 > 21) after MSD.
157 Pregnant within 21 days of MSD (P21) was coded as 1 if cows with at least one 
158 service did not receive a service following 21 days of breeding and was subsequently 
159 confirmed as pregnant. A cow received a P21 record of zero if a service was obtained 
160 sometime after 21 days of breeding, or if the animal was diagnosed as non-pregnant. Similar 
161 criteria were used for pregnant within either 42 (P42) or 84 days (P84) after MSD.
162 MSD to first service interval (MSD-FS) is the interval in days from MSD until the 
163 day of the first service. MSD to conception interval (MSD-CI) is the interval in days from 
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164 MSD until the day of the service that subsequently resulted in successful pregnancy 
165 diagnosis.
166 2.5 Data handling and Statistical analysis
167 All statistical analyses were performed using SAS software v 9.4 (SAS Institute, 
168 Cary, NC, USA). Five cows were culled after first service (Control = 1; GnRH = 2; hCG = 1, 
169 P4OV = 1) and were excluded from the analysis of reproductive performance outcomes 
170 except SR21. The GLIMMIX procedure was used to determine the effect of treatment on 
171 binary variables such as ovulation, SR21, P21, P42, P84, P/AI1, P/AI1≤21 and P/AI1>21. 
172 The model included as fixed effects treatment, parity, DIM, herd and their interactions, and 
173 cow was included as a random effect. The presence of a LF was included as a covariate in the 
174 analysis of ovulation rate. BCS was not included in the model as 88.7% (190/214) of the 
175 animals had a target BCS between 2.75 and 3.25. By design, cows in P4OV treatment 
176 received fixed time AI on the first day of the breeding period and consequently were removed 
177 from SR21 analysis. 
178 The normality of both the raw data and residuals was tested for continuous variables, 
179 and the most appropriate Box-Cox transformation was used in MSD-FS. Mixed model 
180 procedures were used to determine the effect of treatment on MSD-FS and MSD-CI (in 
181 served and pregnant cows, respectively). Treatment, parity, DIM and herd were included as 
182 fixed effects and cow was included as a random effect. 
183 Survival analysis was carried out using PROC LIFETEST procedure of SAS to 
184 examine the effect of treatment on MSD-FS and MSD-CI interval. For both MSD-FS and 
185 MSD-CI, cows that were not served or did not conceive during the study period were right-
186 censored at 84 days (i.e., last day of the study breeding period).
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192 The percentage of animals with no LF on the ovary on the day of enrolment and 
193 treatment initiation was 8.8% (19/214). There was a strong treatment effect on ovulation rate 
194 (P < 0.0001). Control animals had a lower ovulation rate compared with GnRH, hCG and 
195 P4OV treatment cows (Figure 2).  There was no effect of DIM [early: 41/60 (68.3%), mid: 
196 77/106 (72.6%) and late: 30/48 (62.5%); (P = 0.32)], parity [primiparous: 21/32 (65.6%) 
197 second parity: 29/46 (63.0%) and ≥ 3 parity 86/136 (63.2%); (P = 0.97)] and presence of LF 
198 [presence of LF: 122/195 (62.2%) absence of LF 14/19 (73.6%); (P = 0.28)] on ovulation 
199 rate.
200 3.2 Submission rate and P/AI1
201 The main reproductive performance outcomes are summarized in Table 1. The 
202 percentage of animals for which first service occurred during or after the first 21 days of 
203 breeding season was 77.5% (166/214) and 22.5% (48/214), respectively. SR21 was not 
204 affected by treatment (P = 0.74), ovulation rate after treatment (P = 0.63), parity (P = 0.69) or 
205 DIM (P = 0.19) (Table 1). 
206 There was no effect of treatment (P = 0.24) or ovulation rate (P = 0.54) on P/AI1 
207 (Table 1). A tendency (P = 0.10) was observed for greater P/AI1 in primiparous cows 
208 compared with cows in their second parity (+18.8 percentage points) and third or later parity 
209 (+21.7 percentage points). Similarly, there was a tendency (P = 0.10) for greater P/AI1 in 
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210 early calving cows compared with mid (+14.7 percentage points) and late-calving cows 
211 (+16.6 percentage points). P/AI1 in cows that were served during the first 21 days of 
212 breeding season (P/AI1 ≤ 21) was not affected by treatment (P = 0.39) (Table 2). P/AI1 when 
213 insemination occurred after the first 21 days of the breeding period (P/AI > 21) tended to be 
214 affected by treatment (P = 0.10), with both GnRH and hCG treatment cows achieving greater 
215 P/AI1 > 21 than Control cows (see Table 2). Interestingly, there were 9 cows in the hCG 
216 treatment and 6 cows in the GnRH treatment that did ovulate before MSD and become 
217 pregnant at the first insemination between day 31 and day 35 of the breeding period (Figure 
218 4).
219 3.3 P21, P42 and P84
220 The percentage of cows pregnant during the first 21 days of the breeding period 
221 tended to be greater (P = 0.07) in the Control and P4OV treatments compared with GnRH 
222 and hCG treatments (see Table 1). There was a tendency (P = 0.07) for P21 to be affected by 
223 DIM. Early-calving cows had greater P21 compared with mid and late-calving cows (+17.5 
224 and +22.4 percentage points, respectively). No effect of treatment was observed on P42 (P = 
225 0.73) or P84 (P = 0.88). During the first 42 days of the breeding period, primiparous cows 
226 tended (P = 0.09) to have greater pregnancy rate (+ 18 percentage points) compared with 
227 multiparous cows. Ovulation status on day -2 before the breeding season did not affect P21 
228 (P = 0.41), P42 (P = 0.85) or P84 (P = 0.87) (Table 1).
229  3.4 MSD-First service interval and MSD-Conception interval 
230 The MSD-FS interval for each treatment is illustrated in Figure 3. As expected, MSD-
231 FS was affected by treatment (P = 0.0001), but it was not affected by ovulation rate after 
232 treatment (ovulation 16.2 d ±1.7; anovulation 16.5 d ±1.3; P = 0.89), parity (primiparous 18.2 
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233 d ±2.2; second parity 14.6 d ±2.1; third or greater parity 16.3 d ± 1.3; P = 0.42) or DIM 
234 (early-calving 15.0 d ±1.9; mid-calving 16.9 d ±1.4; late-calving 17.2 d ±2.1; P = 0.68). 
235 The MSD-CI for each treatment is illustrated in Figure 4. P4OV had shorter MSD-CI 
236 in all cows (P = 0.02) compared with GnRH and hCG treatments, respectively (25.0 d ±3.2 vs 
237 31.6 d ±2.6; and 35.0 d ±3.5) and tended to be shorter (P= 0.09) compared with Control cows 
238 (29.7 d ±3.6). Differences between P4OV and GnRH and hCG treatments in the number of 
239 days to become pregnant reflected the effect of treatment on pregnancy establishment during 
240 the first 3 weeks of the breeding season, with P4OV treatment cows achieving a greater 
241 percentage of cows pregnant (+14 points percentage) during first 21 days of the breeding 
242 period. MSD-CI was shorter in early-calving compared with late-calving animals [early 24.9 
243 d ±3.0; mid 31.7 d ±2.5; late 35.4 d ±2.5; (P = 0.03)] and tended to be longer in multiparous 
244 compared with primiparous cows [primiparous 25.2 d ±3.6; second parity 29.0 d ±3.1; third 
245 or greater parity 37.2 d ±2.4; (P = 0.07)]. For cows that become pregnant during the breeding 
246 period, MSD-CI was not affected by ovulation rate after treatment [ovulation 20.3 d ±2.8; 
247 anovulation 22.7 d ±1.38; (P = 0.38)]
248 4. Discussion
249 The main finding in this study was that administration of GnRH or hCG 9 days before 
250 MSD increased ovulation rate in anovulatory anestrous cows but did not impact on 
251 reproductive performance during the first 21 days of the breeding period. As expected, 
252 P4OV-treated cows had a shorter MSD-FS and MSD-CI compared with Control, GnRH and 
253 hCG-treated cows, and had greater pregnancy rate in the first 21 days of the breeding season 
254 compared with GnRH and hCG-treated cows.
255 This study specifically examined the effect of treatment 9 days before the start of the 
256 breeding season on ovulation rate and reproductive performance in anovulatory anestrous 
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257 seasonal-calving, pasture-based dairy cows. Cows were selected on the basis that they were 
258 not detected in oestrus and did not have a CL 9 days before MSD. This differs from previous 
259 studies where both cows that were anovular and cows that had ovulated but had not been 
260 detected in oestrus were enrolled [22]. In seasonal calving systems, there is not a defined 
261 voluntary waiting period for all cows. Thus, cows were on average 65 days after calving at 
262 time of treatment but ranged from 30 to 81 days. In the present study, a single injection of 
263 GnRH or a single injection of hCG were examined as potential strategies to simplify herd 
264 management and to reduce costs of treating anovulatory anoestrus cows compared with a 
265 P4OV protocol. Previous studies have focussed on examining the use of P4 alone or the 
266 P4OV protocol as treatments for anoestrous cows [19, 22, 23]. Hence, the results of the 
267 current study are an extension of the previous studies evaluating treatments in anoestrous 
268 cows. 
269 4.1 Ovulation
270 The percentage of animals that were not detected in oestrus by tail-painting in the 
271 present study was 23.1%, which was less than previously reported by Rhodes et al. [18] 
272 [35%]. The percentage of animals that had not been detected in oestrus but did have a CL at 
273 examination, however, was 39.9% (195/488), a finding that was greater than previously 
274 reported by McDougall (2010) [22][between 20% and 30% of anoestrous cows had a CL at 
275 the veterinary examination].
276 Treatment had an effect on ovulation in the present study. Control cows had reduced 
277 ovulation rate compared with the other three treatments. GnRH triggers ovulation by 
278 stimulating a surge release of LH and FSH from the anterior pituitary [24]. Similarly, hCG 
279 exerts potent LH-like effects on the ovary [see review De Rensis et al., 2010 [12]]. Stevenson 
280 et al. [19] reported that 61.3% of anoestrous cows ovulated in response to GnRH injection, 
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281 which is slightly less than in the current study, albeit with different cow genetics and milk 
282 production system. In suckling anoestrous beef cows (21 to 35 DIM), Sheffel et al [25] 
283 reported that 88.0% of cows formed a corpus luteum in response to an injection of 1000 iu of 
284 hCG. Interestingly, we did not find an interaction between treatment and large follicle status 
285 on ovulation rate, in agreement with [25] who stated that follicles smaller than 10 mm in 
286 diameter were able to form luteal tissue in response to hCG. Nevertheless, to the best of our 
287 knowledge, there are no reports on ovulation rate of small follicles (< 10 mm) using GnRH in 
288 anovulatory anestrus dairy cows.
289 4.2 SR21 and MSD-FS
290 The first postpartum ovulation is frequently associated with an absence of oestrous 
291 behaviour and is often followed by a luteal phase of short duration [26]. Horan et al. [27] 
292 reported average first postpartum luteal phase duration of 13.1 ± 0.8 d. Hence, we expected 
293 an increase in the number of services during the first week of the breeding season in GnRH 
294 and hCG treated cows due to greater ovulation rate in these two treatments during the week 
295 before MSD compared with the Control treatment. There were no differences between these 
296 three treatments in MSD-FS interval (Figure 3) or SR21 (Table1). This finding suggests one 
297 or a combination of more than one of the following events occurred: (i) a large proportion of 
298 Control cows had behavioural oestrus expression at the first spontaneous estrus event; (ii) the 
299 duration of the first luteal phase was prolonged in a large proportion of GnRH and hCG 
300 treatment cows that responded to the experimental treatments; or (iii) an increased incidence 
301 of silent oestrus events in GnRH and hCG treatment cows during the first 21 days of the 
302 breeding season.
303 4.3 Reproductive performance 
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304 Thatcher and Wilcox [28] and Darwash et al. [29] previously reported that a greater 
305 number of oestrous cycles before first insemination results in improved fertility at first 
306 service. In the current study, treatment with GnRH or hCG did not affect P/AI1 and P/AI1 ≤ 
307 21. A tendency for greater P21 was observed in P4OV and Control cows compared with 
308 GnRH- or hCG-treated cows. Conversely, there was a tendency for greater P/AI1 in cows that 
309 received their first service event after day 21 of the breeding season (P/AI > 21) in GnRH- 
310 and hCG-treated cows compared with Control treatment cows. These findings might be 
311 explained by differences in the type of ovulation (induced ovulation vs spontaneous 
312 ovulation). Ovulation of smaller follicles results in a smaller CL and lower circulating plasma 
313 P4 concentrations [30]. Hence, in the current study, ovulation induced by GnRH or hCG 
314 treatment might result in lower circulating plasma P4 concentration during the ensuing 
315 oestrous cycle, potentially resulting in oestrous expression failure. In support of this, 9 and 6 
316 cows in the hCG and GnRH treatments group, respectively, did ovulate before MSD, and 
317 become pregnant following their first service between day 31 and day 35 of the breeding 
318 period.  
319 Primiparous and early-calving cows tended to have greater reproductive performance 
320 and had shorter MSD-CI compared with the other categories in agreement with Herlihy et al. 
321 [13] and Rojas Canadas et al. [35]. This might be explained by more favourable energy 
322 balance in primiparous [36] and early-calving cows at the MSD, and shorter time available to 
323 complete uterine involution in mid and late-calving animals. 
324 Cows in the P4OV treatment had shorter MSD-CI compared with cows in the GnRH 
325 and hCG treatments and tended to have shorter MSD-CI interval compared with Control 
326 treatment cows. These differences reflected differences in MSD-FS (all cows in P4OV were 
327 served on the first day of breeding period) and similar P/AI1. MSD-CI in the Control 
328 treatment was shorter than reported by McDougall [22] [29.7 ±3.6 d vs 43.5 d ±2.6]. These 
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329 differences can be explained by differences in the pregnancy rate at first service between 
330 studies (60.0% vs 34.3%). 
331 In conclusion, treatment of anoestrous cows resulted in an increase in ovulation rate 
332 compared with untreated Control cows. While treatment did not improve overall reproductive 
333 performance in GnRH and hCG treated cows compared with Control cows, P/AI1 > 21 
334 tended to be improved. A tendency for greater pregnancy during the first 21 days of the 
335 breeding period was observed in Control and P4OV treatment cows. It is apparent from the 
336 findings in the present study that stimulating ovulation in anoestrous cows with a single 
337 injection of either GnRH or hCG on day 9 before MSD was not a useful strategy to improve 
338 herd reproductive performance. The observed tendency for greater P/AI in GnRH and hCG 
339 treated cows when that first service event occurred after the first 21 days of the breeding 
340 period suggests that earlier administration of these treatments could have had a beneficial 
341 effect on reproductive performance and warrants further investigation.
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447 Figure 1. Schematic outline of activities. Tail painting:  Whole herds were marked with tail paint 35 days before MSD to 
448 monitor oestrous behaviour. BCS = body condition score; 5-point scale. US1: First ultrasound examination to all cows 
449 with intact tail paint to identify cows as cycling or non-cycling and to assess uterine health. US2: Second ultrasound 
450 examination of all treated cows to assess the effect of treatment on ovulation. PD = Pregnancy diagnosis on day 36 ± 6 
451 after first service by ultrasound. MSD = mating start date. MED = mating end date, end of breeding season. CL = corpus 




454 Figure 2. Effect of treatment on ovulation rate (P < 0.0001) measured 7 days after administration of 
455 experimental treatments. Control (no treatment); GnRH treatment (0.1 mg gonadorelin diacetate); hCG 










464 Figure 3.  Kaplan–Meier survival curve for effect of treatment on mating start date to first service 
465 interval (MSD-FS). Control (no treatment); GnRH: 2mL of gonadotropin releasing hormone; hCG: 
466 1500 IU of human chorionic gonadotropin; P4OV treatment (progesterone-Ovsynch protocol). There 






471 Figure 4.  Kaplan–Meier survival curve for effect of treatment on mating start date to conception interval (MSD-
472 CI). Top: All cows. Bottom: Only cows that did ovulate before MSD. Control (no treatment); GnRH treatment 
473 (0.1 mg gonadorelin diacetate); hCG treatment (1500 IU of human chorionic gonadotropin); P4OV treatment 
474 (progesterone-Ovsynch protocol); There was a significant effect on MSD-CI (P = 0.02). Cows that failed to 




477 Table 1. Effect of ovulation after treatment, treatment (control, GnRH, hCG or Progesterone Ovsynch 
478 protocol), parity and days in milk on reproductive performance
SR21 P value P/AI1 P value P21 P value P42 P value P84 P value
Ovulation after 
treatment
    Yes  79.5% 
(109/137)





























































































































479 Control: No treatment; GnRH: Gonadotropin releasing hormone; hCG: Human chorionic gonadotropin; P4OV: 7 days-
480 Progesterone-Ovsynch protocol; Significant differences when (P < 0.05). Tendency when (0.05 = P ≤ 0.10). a bDifferent 





484 Table 2. Effect of treatment (control, gonadotropin releasing hormone, human chorionic gonadotropin 
485 or 7 days-Progesterone Ovsynch protocol) on pregnancy rate at first service during and after 21 days 
486 of mating start date
     Control       GnRH       hCG       P4OV     P-value
P/AI1≤21 58.8%     
(20/34)
57.1%     
(20/35)
48.4%     
(16/33)
45.7%     
(27/59)
0.39
P/AI1>21 50.0%a       
(7/14)
72.7%b     
(14/19)




488 P/AI≤21: Pregnancy rate at first service during first 21 days of breeding period. P/AI≥21: Pregnancy rate at first service after 
489 21 days of mating start date. Control: No treatment; GnRH: Gonadotropin releasing hormone; hCG: Human chorionic 
490 gonadotropin; 7 days-P4OV: Progesterone-Ovsynch; Significant differences when (P < 0.05). Tendency when (0.05 = P ≤ 




A single injection of GnRH or hCG increased ovulation rate compared with untreated Control cows.
GnRh or hCG treatment did not improve overall reproductive performance.
